2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
The Senate is expected to consider and vote on a bill passed by the House on March 27 that includes language to patch the sustainable growth rate (SGR) formula for 12 months and delay ICD-10 implementation until at least October 1, 2015
The Senate is expected to consider and vote on a bill passed by the House on March 27 that includes language to patch the sustainable growth rate (SGR) formula for 12 months and delay ICD-10 implementation until at least October 1, 2015. Industry stakeholders would much prefer a permanent fix to the SGR formula, but most are in favor of a stopgap measure to prevent a 24% drop in Medicare reimbursement rates from going into effect on April 1.
The bill, HR 4302, calls for a 0.5% update through December 31, 2014 and a 0% update from January 1, 2015 through March 31, 2015. For passage, the bill must receive 60 affirmative votes from the Senate. Reportedly, the Senate will not be able to remove any sections of the bill before a vote, including the ICD-10 delay provision, which would prohibit the Department of Health and Human Services from implementing the transition at any point before October 1, 2015. This likely means that the bill will pass.
Roberta Buell of onPoint Oncology says that “there are many moving parts to this bill that symbolize deals that were made to appease certain factions in an election year.” In addition, Buell says the bill includes provisions for value-added purchasing for imaging and re-valuation of clinical laboratory tests to align them with private payers.
In her newsletter that covers reimbursement issues, she highlights the following sections of HR 4302 that are of interest: